Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET ® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical ...
The Indian smartwatch market has never been more exciting or more competitive. Very often, we get new options, yet one device ...
21h
Premium smartwatches starting at ₹6999: Smart choices for work, workouts and everything in between
Looking for a smartwatch that fits your routine without overspending? Here are premium smartwatches starting at ₹6999, built ...
The Hearty Soul on MSN
14 things to do (and never do) before your next doctor appointment
Most people spend more time picking an outfit for their doctor’s visit than actually preparing for it. You show up, answer the same questions about your family history, and walk out wondering why that ...
Masimo (Nasdaq:MASI) today announced new study findings supporting the use of its SET pulse oximetry in critically ill neonates.
Introduction Traumatic brain injury (TBI), a leading cause of global morbidity and mortality, has notably poorer outcomes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results